Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies
Authors:
Open Access
- 1 December 2016
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 206, 151-160
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- An abbreviated version of the brief assessment of cognition in schizophrenia (BACS)The European Journal of Psychiatry, 2015
- Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisThe Lancet, 2009
- Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity DisorderThe Journal of Clinical Psychiatry, 2008
- Psychostimulants for depressionCochrane Database of Systematic Reviews, 2008
- Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and SleepinessJournal of Clinical Psychopharmacology, 2007
- Face-to-face versus remote administration of the Montgomery-Asberg Depression Rating Scale using videoconference and telephoneDepression and Anxiety, 2007
- Modafinil Augmentation of Selective Serotonin Reuptake Inhibitor Therapy in MDD Partial Responders with Persistent Fatigue and SleepinessAnnals of Clinical Psychiatry, 2007
- Size of Treatment Effects and Their Importance to Clinical Research and PracticeBiological Psychiatry, 2006
- Efficacy and Tolerability of Tricyclic Antidepressants and SSRIs Compared With Placebo for Treatment of Depression in Primary Care: A Meta-AnalysisThe Annals of Family Medicine, 2005
- Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive DisorderThe Journal of Clinical Psychiatry, 2003